Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santen Pharmaceutical Co Ltd
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co LtdfiledCriticalSanten Pharmaceutical Co Ltd
Priority to JP57185026ApriorityCriticalpatent/JPS5973515A/ja
Priority to US06/488,100prioritypatent/US4552765A/en
Priority to IT21040/83Aprioritypatent/IT1164218B/it
Priority to GB08313145Aprioritypatent/GB2123815B/en
Priority to DE3317529Aprioritypatent/DE3317529C2/de
Priority to FR8308048Aprioritypatent/FR2526792B1/fr
Publication of JPS5973515ApublicationCriticalpatent/JPS5973515A/ja
Publication of JPH0224248B2publicationCriticalpatent/JPH0224248B2/ja
Therapeutic agent for inflammatory bowel disease comprising 2-amino-1,3-propanaediol derivative as active ingredient, and method for treatment of inflammatory bowel disease